AniAMPpred

AniAMPpred predicts antimicrobial peptides (AMPs) across animal genomes using machine learning and sequence analysis to identify probable antimicrobial proteins (PAPs).


Key Features:

  • Machine Learning Integration: Combines support vector machine (SVM) classification with deep learning-derived sequence features to predict antimicrobial activity.
  • Comprehensive Dataset Utilization: Trained on a curated dataset of known AMPs from animal species spanning 10–200 amino acids.
  • High Predictive Accuracy: Demonstrated superior performance compared to existing classifiers in distinguishing AMPs from non-AMPs.
  • Genome-Wide Application: Applicable genome-wide to identify PAPs across animal species, including identification of 436 PAPs in Helobdella robusta.
  • Functional Validation Support: Supports functional validation via BLAST analysis against known AMP databases.

Scientific Applications:

  • Antimicrobial Research: Identification of novel AMPs for investigation as antimicrobial agents against antibiotic-resistant pathogens.
  • Protein Function Annotation: Annotation of protein functions within genomic databases to reveal roles in host defense mechanisms.
  • Evolutionary Studies: Analysis of evolutionary conservation and divergence of AMPs across different animal species.

Methodology:

Model training used a curated dataset of known AMPs (10–200 amino acids); features were derived via deep learning and classified using a support vector machine (SVM), and predicted proteins can be validated by BLAST against AMP databases.

Topics

Details

Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
11/18/2021
Last Updated:
11/18/2021

Operations

Publications

Sharma R, Shrivastava S, Kumar Singh S, Kumar A, Saxena S, Kumar Singh R. AniAMPpred: artificial intelligence guided discovery of novel antimicrobial peptides in animal kingdom. Briefings in Bioinformatics. 2021;22(6). doi:10.1093/bib/bbab242. PMID:34259329.

PMID: 34259329
Funding: - National Academy of Agricultural Sciences: NASF/ABA-6014/2016-17/367